ANBENITAMAB
UNII RHS90QRF9E

Substance Identification & Data

This profile provides standardized clinical and technical data for Anbenitamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RHS90QRF9E.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2367012-88-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

RHS90QRF9E

CAS Registry Number

2367012-88-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANBENITAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C162577

National Cancer Institute reference terminology for clinical and research data.

INN ID

11611

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anbenitamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ANBENITAMAB

Common Names & Synonyms

ANBENITAMAB [INN]

ANTI-HER2 BSAB KN026

IMMUNOGLOBULIN G1 (369-SERINE,371-ALANINE,408-LYSINE,410-VALINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2 DOMAIN IV)(HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB 4D5 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB 4D5 .KAPPA.-CHAIN, (229->228'),(232->231')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (368-TRYPTOPHAN,411-ALANINE) ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2 DOMAIN II)(HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB 2C4 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RHUMAB 4D5 .KAPPA.-CHAIN

KN 026 [WHO-DD]